QX-314 bromide is a blocker of the membrane-impermeable permanently charged sodium channel.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
200 mg | 2-3 weeks | $ 1287 | |
400 mg | 2-3 weeks | $ 2316 | |
800 mg | 2-3 weeks | $ 3280 | |
2 g | 2-3 weeks | $ 6893 | |
4 g | 2-3 weeks | $ 10477 |
Description | QX-314 bromide is a blocker of the membrane-impermeable permanently charged sodium channel. |
In vitro | QX-314 bromide inhibits calcium currents in hippocampal CA1 pyramidal neurons intracellular, and the low-threshold (T-type) Ca2+ currents are on average < 10% of control amplitude. QX-314 bromide exerts biphasic effects on transient receptor potential vanilloid subtype 1 channels in vitro. QX-314 bromide shifts the current-voltage relationships (I-Vs) in the positive voltage direction due to the presence of intracellular Br-. QX-314 bromide (≥ 30 mM) produces oocyte membrane blackening and cell death. QX-314 bromide (1–60 mM) directly activates TRPV1 in a concentration-dependent manner . |
In vivo | QX-314 bromide (1.6 mg/kg; i.c.) abolishes responses to noxious mechanical and thermal stimuli . |
CAS No. | 24003-58-5 |
Chemical Formula | C16H27BrN2O |
Molecular Weight | 343.3 |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom